Boston Scientific has grown revenue 16% a year over three years and 13% a year over five, with earnings per share compounding at 60%. Revenue growth, 3-year annual rate: +16% (Medical Devices median +12%). Revenue growth, 5-year rate: +13%, growth has picked up over the last three years. Earnings per share, 3-year rate: +60%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 19, FY2007 to FY2025, as filed.

BSXBoston Scientific

Healthcare

$42.75-56% 1Y

$42.75

$41.5852 weeks$104.98

Is it growing?

Excellent

Growing: revenue growing +14% year on year, earnings up +47% year on year, and operating margin widening (+2.7 points).

3 good

Revenue trend+14% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +13% a year.

Earnings trend+47% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction+2.7 points operating

Trailing-twelve-month operating margin, 19.8% now against 17.0% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbetter than 83% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is BSX growing?

Boston Scientific has grown revenue 16% a year over three years and 13% a year over five, with earnings per share compounding at 60%.

+16%

Revenue growth, 3-year annual rate · Medical Devices median +12% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +13%
Revenue growth, 5-year rate · +16% over three · growth has picked up over the last three years
Earnings per share, 3-year rate: +60%
Earnings per share, 3-year rate · revenue +16% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 19
Years of annual history on file · FY2007 to FY2025, as filed